An Exploratory Clinical Study on the Safety and Efficacy of Anti-CD19/BCMA U CAR-T Cells in the Treatment of Relapsed/Refractory Immune-mediated Kidney Disease
Clinical trial NCT07241468 · RECRUITING
Trial details
- NCT number
- NCT07241468
- Sponsor
- Changhai Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-15
- Primary completion
- 2026-12-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.